san 58035 has been researched along with ici 164384 in 1 studies
Studies (san 58035) | Trials (san 58035) | Recent Studies (post-2010) (san 58035) | Studies (ici 164384) | Trials (ici 164384) | Recent Studies (post-2010) (ici 164384) |
---|---|---|---|---|---|
58 | 1 | 12 | 234 | 0 | 2 |
Protein | Taxonomy | san 58035 (IC50) | ici 164384 (IC50) |
---|---|---|---|
Estrogen receptor | Homo sapiens (human) | 0.195 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Balaguer, P; Boubekeur, N; de Medina, P; Favre, G; Poirot, M; Silvente-Poirot, S | 1 |
1 other study(ies) available for san 58035 and ici 164384
Article | Year |
---|---|
The prototypical inhibitor of cholesterol esterification, Sah 58-035 [3-[decyldimethylsilyl]-n-[2-(4-methylphenyl)-1-phenylethyl]propanamide], is an agonist of estrogen receptors.
Topics: Amides; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Enzyme Inhibitors; Estradiol; Humans; Models, Molecular; Organosilicon Compounds; Polyunsaturated Alkamides; Receptors, Estrogen; Sterol O-Acyltransferase; Transcription, Genetic | 2006 |